Larimar Therapeutics, Inc.·4

May 11, 4:29 PM ET

LEFF JONATHAN S 4

4 · Larimar Therapeutics, Inc. · Filed May 11, 2023

Insider Transaction Report

Form 4
Period: 2023-05-09
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-09+8,3008,300 total
    Exercise: $5.09Exp: 2033-05-09Common Stock (8,300 underlying)
Footnotes (2)
  • [F1]The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.
  • [F2]The options vest on the earlier of (a) May 9, 2024 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES